Alpha Therapy

Alpha Therapy

 

various methods of therapeutic influence on an organism, primarily by alpha particles. Several short-lived isotopes or those that separate quickly from the organism (radon, daughter products of thoron, and others) are used in alpha therapy. These isotopes produce alpha, beta, and gamma radiation; however, during therapy the organism mainly absorbs alpha particles (about 90 percent). The therapy is administered through radon baths (general and local), drinking of radon water, microsyringe, irrigations, inhalation of air enriched with radon, and so on, as well as by application to certain areas of the patient’s skin of radioactive bandages—gauze applicators with daughter products of thoron—or ointments and solutions with thorium X. Alpha therapy favorably affects the functional state of the central and autonomic nervous system, the endocrine glands, and the cardiovascular system; the therapy has a calming, pain-killing, and anti-inflammatory effect and the like. It is indicated for illnesses of the peripheral nervous system, phantom pains, neurasthenia, thyrotoxicosis (in the early stage), and other conditions. It is contraindicated for malignant tumors, tuberculosis, certain blood diseases, during pregnancy, and the like.

Alpha therapy is used at resorts with natural radon factors (water, air), like Piatigorsk, Tskhaltubo, Belokurikha, Brambach (German Democratic Republic), Gastein (Austria), and Jachymov (Czechoslovakia), as well as under nonresort conditions, in which case radon water is prepared using solutions of radium 220/86.

E. S. SHCHEPOT’EVA

References in periodicals archive ?
M2 EQUITYBITES-April 2, 2019-Nordic Nanovector announces promising results from preclinical research collaboration to develop novel CD37-targeting alpha therapy for B-cell tumours
Global Banking News-April 2, 2019-Nordic Nanovector announces promising results from preclinical research collaboration to develop novel CD37-targeting alpha therapy for B-cell tumours
NORDIC BUSINESS REPORT-April 2, 2019-Nordic Nanovector announces promising results from preclinical research collaboration to develop novel CD37-targeting alpha therapy for B-cell tumours
M2 PHARMA-April 2, 2019-Nordic Nanovector announces promising results from preclinical research collaboration to develop novel CD37-targeting alpha therapy for B-cell tumours
Kitas, "Anti-tumour necrosis factor alpha therapy improves insulin sensitivity in normal-weight but not in obese patients with rheumatoid arthritis," Arthritis Research & Therapy, vol.
A safety assessment of anti-tumor necrosis factor alpha therapy for treatment of Crohn's disease.
Key Words: Anxiety, Interferon alpha Therapy, Depression
Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national survey.
Anti-tumor necrosis factor alpha therapy and the risk of serious bacterial infections in elderly patients with rheumatoid arthritis.
[2.] Joyau C, Veyrac G, Dixneuf V, Jolliet P: Anti-tumour necrosis factor alpha therapy and increased risk of de novo psoriasis: is it really a paradoxical side effect?
Acute pericarditis due to pegylated interferon alpha therapy for chronic HCV hepatitis case report.